Updated May 12, 2020

Joao Curado

Send Message

Flomics developed a cloud-based platform that helps hospitals, clinics and research laboratories to extract the most of NGS data. It takes any kind of COVID-19 sequencing experiment and generates interpretable clinical information (phylogeny, etc)

Data
  
Testing
  

Stage 4: Transition to Scale

We are already working with a few selected laboratories and preparing everything to start capturing the global market.

Focus Areas:

Health, Data/Analytics, Infectious & Vector Diseases and 1 MoreSEE ALL

Health, Data/Analytics, Infectious & Vector Diseases and Prevention & VaccinationSEE LESS

Implemented In:

Switzerland and Spain

Switzerland and SpainSEE LESS

2
Countries Implemented In
50
Customers
6
Employees
$150,000
Funds Raised to Date

The Team Behind the Innovation

Joao Curado (CEO), the entrepreneurial lead, is the developer of Flomics’ bioinformatic pipelines and the responsible for the daily operations Esther Lizano (CSO) is the molecular biologist that developed the experimental protocols and an expert in RNA and next-generation sequencing (NGS) techniques Luis Korrodi (CBO) brings a vast experience in healthcare consultancy and acts has the market access, business development and regulatory affairs lead

EXECUTIVE TEAM INCLUDES WOMEN

Milestone

Date Unknown
New Country Implemented In
Spain
Date Unknown
New Country Implemented In
Switzerland

Supporting Materials

2020-orientation-null.04-Flomics-presentation-covid19.pdf